Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tor Skomedal

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Primary Health Care|August 17, 2017
New benzodiazepine and Z-hypnotic users and disability pension: an eight-year nationwide observational follow-up studyIngunn F Tvete, Trine Bjørner, Tor Skomedal
Health Services Research and Managerial Epidemiology|September 6, 2018
Mental Health and Disability Pension Onset: Changes in Consumption of Antianxiety and Hypnotic DrugsIngunn Fride Tvete, Trine Bjørner, Tor Skomedal
Scandinavian Journal of Primary Health Care|December 20, 2015
Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in NorwayIngunn Fride Tvete, Trine Bjørner, Tor Skomedal
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 12, 2016
A 5-year follow-up study of users of benzodiazepine: starting with diazepam versus oxazepamIngunn Fride Tvete, Trine Bjørner, Tor Skomedal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 1, 2013
[Dispensing of benzodiazepines and Z drugs by Norwegian pharmacies 2004-2011]Trine Bjørner, Ingunn Fride Tvete, Ivar Aursnes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 15, 2013
Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndromeTor Skomedal, Sigrid Hanem, Terje Dybvik, et al.
Analytical Biochemistry|October 4, 2008
Calculating reaction rate constants and estimating the efficacy of selective enzyme inhibitorsHilde Eikemo, Tor Skomedal, Finn Olav Levy, et al.
BMJ Open|October 8, 2013
A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribingIngunn Fride Tvete, Trine Bjørner, Ivar Andreas Aursnes, et al.
Toxicology|March 15, 2008
Pro-inflammatory potential of ultrafine particles in mono- and co-cultures of primary cardiac cellsAnnike I Totlandsdal, Tor Skomedal, Marit Låg, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 23, 2017
Ivar Prydz Gladhaug, Tor Skomedal, Jørg Mørland, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Primary Health Care|August 17, 2017
New benzodiazepine and Z-hypnotic users and disability pension: an eight-year nationwide observational follow-up studyIngunn F Tvete, Trine Bjørner, Tor Skomedal
Health Services Research and Managerial Epidemiology|September 6, 2018
Mental Health and Disability Pension Onset: Changes in Consumption of Antianxiety and Hypnotic DrugsIngunn Fride Tvete, Trine Bjørner, Tor Skomedal
Scandinavian Journal of Primary Health Care|December 20, 2015
Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in NorwayIngunn Fride Tvete, Trine Bjørner, Tor Skomedal
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 12, 2016
A 5-year follow-up study of users of benzodiazepine: starting with diazepam versus oxazepamIngunn Fride Tvete, Trine Bjørner, Tor Skomedal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 1, 2013
[Dispensing of benzodiazepines and Z drugs by Norwegian pharmacies 2004-2011]Trine Bjørner, Ingunn Fride Tvete, Ivar Aursnes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 15, 2013
Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndromeTor Skomedal, Sigrid Hanem, Terje Dybvik, et al.
Analytical Biochemistry|October 4, 2008
Calculating reaction rate constants and estimating the efficacy of selective enzyme inhibitorsHilde Eikemo, Tor Skomedal, Finn Olav Levy, et al.
BMJ Open|October 8, 2013
A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribingIngunn Fride Tvete, Trine Bjørner, Ivar Andreas Aursnes, et al.
Toxicology|March 15, 2008
Pro-inflammatory potential of ultrafine particles in mono- and co-cultures of primary cardiac cellsAnnike I Totlandsdal, Tor Skomedal, Marit Låg, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 23, 2017
Ivar Prydz Gladhaug, Tor Skomedal, Jørg Mørland, et al.
Pageof 5